Impact of the natural compound urolithin A on health, disease, and aging
Calculating units for non-standard doses The titration schedule uses standard dose levels (0.25, 0.5, 1.0, 1.7, 2.4 mg), but your protocol might call for different amounts
Your Annual Physical Manual Data Processing Guesswork Trend Detection Once-a-year physical Reactive, tested when sick No data between visits Once a year testing Delayed Results One-size dosing, set and forget Real-Time Trend Insights Daily smart-device data Automated Data Sync Quarterly Biomarker Tests Optimal, personalized targets Plain-language AI insights Medications titrated to your data Built to extend healthspan Frequently Asked Questions Clarity before you commit Answers on setup, scale, and support to remove blockers.
Earlier phase 1 and 2 studies demonstrated that cagrilintide was well-tolerated, exhibiting a safety profile consistent with FDA-approved GLP-1 receptor agonists like semaglutide and liraglutide, as well as the amylin analog pramlintide [1]